DOH acknowledges push for medical cannabis legalization
Emphasizes distinction between medical and recreational use, highlights regulatory considerations
The Department of Health (DOH) has recognized ongoing efforts towards the legalization of medical cannabis, emphasizing its differentiation from recreational marijuana use.

In a statement on Tuesday, Feb. 13, the DOH underlined that any initiatives regarding medical cannabis legalization must be grounded in the best available scientific evidence, carefully evaluated for cost-effectiveness, and assessed for their potential impact on public health.
Moreover, the agency stressed the importance of considering the regulatory capacity of all government bodies that would be involved in the implementation and oversight of such legislation.
However, the DOH said they “do not endorse” either the cultivation of cannabis plants or the manufacturing of cannabis products.
As a reminder to the public, it reiterated that the use of marijuana remains “illegal” under current Philippine law unless individuals are granted a compassionate special permit (CSP) signed by the Director General of the Food and Drug Administration (FDA).
This permit would authorize the use and importation of medical marijuana products into the country.
The DOH assured the public that any updates or developments regarding the use of medical cannabis would be promptly communicated.